OWA
Opal Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $483K | Sell |
1,191
-195
| -14% | -$79.1K | 0.13% | 85 |
|
2025
Q1 | $690K | Buy |
1,386
+200
| +17% | +$99.5K | 0.21% | 56 |
|
2024
Q4 | $617K | Sell |
1,186
-250
| -17% | -$130K | 0.19% | 78 |
|
2024
Q3 | $888K | Buy |
1,436
+198
| +16% | +$122K | 0.28% | 51 |
|
2024
Q2 | $685K | Buy |
1,238
+128
| +12% | +$70.8K | 0.22% | 56 |
|
2024
Q1 | $645K | Buy |
1,110
+306
| +38% | +$178K | 0.22% | 63 |
|
2023
Q4 | $427K | Buy |
804
+43
| +6% | +$22.8K | 0.17% | 91 |
|
2023
Q3 | $385K | Buy |
761
+20
| +3% | +$10.1K | 0.23% | 74 |
|
2023
Q2 | $387K | Sell |
741
-5
| -0.7% | -$2.61K | 0.19% | 67 |
|
2023
Q1 | $430K | Sell |
746
-8
| -1% | -$4.61K | 0.25% | 47 |
|
2022
Q4 | $415K | Buy |
754
+135
| +22% | +$74.3K | 0.23% | 62 |
|
2022
Q3 | $314K | Sell |
619
-24
| -4% | -$12.2K | 0.23% | 62 |
|
2022
Q2 | $349K | Buy |
643
+17
| +3% | +$9.23K | 0.23% | 57 |
|
2022
Q1 | $370K | Sell |
626
-198
| -24% | -$117K | 0.32% | 49 |
|
2021
Q4 | $550K | Buy |
824
+54
| +7% | +$36K | 0.35% | 49 |
|
2021
Q3 | $440K | Sell |
770
-5
| -0.6% | -$2.86K | 0.42% | 33 |
|
2021
Q2 | $391K | Buy |
775
+66
| +9% | +$33.3K | 0.36% | 40 |
|
2021
Q1 | $324K | Sell |
709
-223
| -24% | -$102K | 0.35% | 36 |
|
2020
Q4 | $434K | Buy |
+932
| New | +$434K | 0.54% | 26 |
|